| Issue Date |
Title |
Author(s) |
| 2019 |
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china |
Wei, Lai;Xu, Xiaoyuan;Guan, Yujuan;Zheng, Sujun;Sheng, Ji-Fang;Yang, Xingxiang;Ma, Yuanji;Huang, Yan;Kang, Yi;Wen, Xiaofeng;Li, Jun;Tan, Youwen;He, Qing;Xie, Qing;Wang, Maorong;An, Ping;Gong, Guozhong;Liu, Huimin;Ning, Qin;Hua, Rui;Ning, Bo;Xie, Wen;Zhang, Jiming;Huang, Wenxiang;Yang, Yongfeng;Lin, Minghua;Zhao, Yingren;Yu, Yanhong;Jia, Ji-Dong;Yang, Dongliang;Chen, Liang;Ye, Yinong;Nan, Yuemin;Gong, Zuojong;Zhang, Quan;Hu, Peng;Wang, Fu-Sheng;Li, Yongguo;Li, Dongliang;Jia, Zhansheng;Hou, Jinlin;Chen, Chengwei;Wu, Jinzi |
| Mar-2020 |
Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy |
Fan, Rong;Zhou, Bin;Xu, Min;Tan, Deming;Niu, Junqi;Wang, Hao;Ren, Hong;Chen, Xinyue;Wang, Maorong;Ning, Qin;Shi, Guangfeng;Sheng, Jifang;Tang, Hong;Bai, Xuefan;Liu, Shi;Lu, Fengmin;Peng, Jie;Sun, Jian;Xie, Qing;Hou, Jinlin;Wan, Mobin;Chen, Shijun;Yu, Yanyan;Ma, Hong;Cheng, Jun;Zhang, Hongfei;Liu, Huimin;Gao, Zhiliang;Sun Yat-Sen;Dou, Xiaoguang |
| 2011 |
Belief in a Just World When Encountering the 5/12 Wenchuan Earthquake |
Xie, Xiaofei;Liu, Huimin;Gan, Yiqun |
| Dec-2020 |
The Diversified Impacts of Urban Morphology on Land Surface Temperature among Urban Functional Zones |
Gao, Sihang;Zhan, Qingming;Yang, Chen;Liu, Huimin |
| 2018 |
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China |
Wei, Lai;Xu, Xiaoyun;Guan, Yujuan;Zheng, Sujun;Sheng, Jifang;Yang, Xingxiang;Ma, Yuanji;Huang, Yan;Kang, Yi;Wen, Xiaofeng;Li, Jun;Tan, Youwen;He, Qing;Xie, Qing;Wang, Maorong;An, Ping;Gong, Guozhong;Liu, Huimin;Ning, Qin;Hua, Rui;Ning, Bo;Xie, Wen;Zhang, Jiming;Huang, Wenxiang;Yang, Yongfeng;Lin, Minghua;Zhao, Yingren;Yu, Yanhong;Jia, Jidong;Yang, Dongliang;Chen, Liang;Ye, Yinong;Nan, Yuemin;Gong, Zuojiong;Zhang, Quan;Hu, Peng;Wang, FuSheng;Li, Yongguo;Li, Dongliang;Jia, Zhansheng;Hou, Jinlin;Chen, Chengwei |
| 2018 |
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China |
Wei, Lai;Xu, Xiaoyun;Guan, Yujuan;Zheng, Sujun;Sheng, Jifang;Yang, Xingxiang;Ma, Yuanji;Huang, Yan;Kang, Yi;Wen, Xiaofeng;Li, Jun;Tan, Youwen;He, Qing;Xie, Qing;Wang, Maorong;An, Ping;Gong, Guozhong;Liu, Huimin;Ning, Qin;Hua, Rui;Ning, Bo;Xie, Wen;Zhang, Jiming;Huang, Wenxiang;Yang, Yongfeng;Lin, Minghua;Zhao, Yingren;Yu, Yanhong;Jia, Jidong;Yang, Dongliang;Chen, Liang;Ye, Yinong;Nan, Yuemin;Gong, Zuojiong;Zhang, Quan;Hu, Peng;Wang, FuSheng;Li, Yongguo;Li, Dongliang;Jia, Zhansheng;Hou, Jinlin;Chen, Chengwei |
| 2019 |
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China |
Xu, Xiaoyuan;Feng, Bo;Guan, Yujuan;Zheng, Sujun;Sheng, Jifang;Yang, Xingxiang;Ma, Yuanji;Huang, Yan;Kang, Yi;Wen, Xiaofeng;Li, Jun;Tan, Youwen;He, Qing;Xie, Qing;Wang, Maorong;Anl, Ping;Gong, Guozhong;Liu, Huimin;Nine, Qin;Hua, Rui;Ning, Bo;Xie, Wen;Zhang, Jiming;Huang, Wenxiang;Yang, Yongfeng;Lin, Minghua;Zhao, Yingren;Yu, Yanhong;Jia, Jidong;Yang, Dongliang;Chen, Liang;Ye, Yinong;Nan, Yuemin;Gong, Zuojiong;Zhang, Quan;Hu, Peng;Wang, Fusheng;Li, Yongguo;Li, Dongliang;Jia, Zhansheng;Hou, Jinlin;Chen, Chengwei;Wu, Jinzi J.;Wei, Lai |
| 2019 |
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL |
Wei, Lai;Xu, Xiaoyuan;Zheng, Sujun;Guan, Yujuan;Sheng, Jifang;Yang, Xingxiang;Ma, Yuanji;Huang, Yan;Kang, Yi;Wen, Xiaofeng;Li, Jun;Tan, Youwen;He, Qing;Xie, Qing;Wang, Maorong;An, Ping;Gong, Guozhong;Liu, Huimin;Ning, Qing;Hua, Rui;Ning, Bo;Xie, Wen;Zhang, Jiming;Huang, Wenxiang;Yang, Yongfeng;Lin, Minghua;Zhao, Yingren;Yu, Yanhong;Jia, Jidong;Yang, Dongliang, Sr.;Chen, Liang;Ye, Yinong, Sr.;Nan, Yuemin;Gong, Zuojiong;Zhang, Quan;Hu, Peng;Wang, FuSheng;Li, Yongguo;Li, Dongliang;Jia, Zhansheng;Hou, Jinlin;Chen, Chengwei;Wu, Jinzi |
| Oct-2020 |
Estimating PM2.5 Concentrations Using Spatially Local Xgboost Based on Full-Covered SARA AOD at the Urban Scale |
Fan, Zhiyu;Zhan, Qingming;Yang, Chen;Liu, Huimin;Bilal, Muhammad |
| Sep-2020 |
How Did Distribution Patterns of Particulate Matter Air Pollution (PM(2.5)and PM10) Change in China during the COVID-19 Outbreak: A Spatiotemporal Investigation at Chinese City-Level |
Fan, Zhiyu;Zhan, Qingming;Yang, Chen;Liu, Huimin;Zhan, Meng |
| Jul-2022 |
How do greenspace landscapes affect PM2.5 exposure in Wuhan? Linking spatial-nonstationary, annual varying, and multiscale perspectives |
Zhan, Qingming;Yang, Chen;Liu, Huimin |
| 1-Jun-2021 |
Impacts of the evolving urban development on intra-urban surface thermal environment: Evidence from 323 Chinese cities |
Liu, Huimin;Huang, Bo;Gao, Sihang;Wang, Jiong;Yang, Chen;Li, Rongrong |
| 2017 |
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score |
Li, Xiaoshu;Gao, Fangyuan;Liu, Huimin;Zhang, Henghui;Liu, Yao;Ye, Xieqiong;Geng, Mingfan;Sun, Le;Wang, Rui;Li, Yuxin;Jiang, Yuyong;Wang, Xiaojing;Zhou, Guiqin;Yang, Zhiyun;Li, Ang;Zeng, Hui;Wang, Xianbo |
| Sep-2021 |
Nursing of a Non-Hodgkin's Lymphoma Patient with a Facial Malignant Fungating Wound |
You, Miaoning;Zhang, Shiyi;Ma, Xiaoxiao;Liu, Huimin;Lu, Yuhan;Li, Yue |
